GERN
Geron Corp
Price:  
1.26 
USD
Volume:  
6,407,067.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN EV/EBITDA

-185.2%
Upside

As of 2026-09-27, the EV/EBITDA ratio of Geron Corp (GERN) is -34.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GERN's latest enterprise value is 995.43 mil USD. GERN's TTM EBITDA according to its financial statements is -28.78 mil USD. Dividing these 2 quantities gives us the above GERN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.6x - 16.6x 16.0x
Forward P/E multiples 17.8x - 19.9x 18.8x
Fair Price (1.09) - (1.04) (1.07)
Upside -186.5% - -182.3% -185.2%
1.26 USD
Stock Price
(1.07) USD
Fair Price

GERN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-24 -34.58
2026-09-23 -34.14
2026-09-22 -35.70
2026-09-21 -35.47
2026-09-18 -35.47
2026-09-17 -35.92
2026-09-16 -35.25
2026-09-15 -35.70
2026-09-14 -37.03
2026-09-11 -36.59
2026-09-10 -37.03
2026-09-09 -37.70
2026-09-08 -40.15
2026-09-04 -41.49
2026-09-03 -40.15
2026-09-02 -41.94
2026-09-01 -39.49
2026-08-31 -39.71
2026-08-28 -40.15
2026-08-27 -40.60
2026-08-26 -40.60
2026-08-25 -41.05
2026-08-24 -40.38
2026-08-21 -40.38
2026-08-20 -41.05
2026-08-19 -41.94
2026-08-18 -40.60
2026-08-17 -40.60
2026-08-14 -39.26
2026-08-13 -40.71
2026-08-12 -41.49
2026-08-11 -42.83
2026-08-10 -39.49
2026-08-07 -39.49
2026-08-06 -41.49
2026-08-05 -42.83
2026-08-04 -36.37
2026-08-03 -35.03
2026-07-31 -35.25
2026-07-30 -36.37
2026-07-29 -37.70
2026-07-28 -38.82
2026-07-27 -39.49
2026-07-24 -38.15
2026-07-23 -38.82
2026-07-22 -37.93
2026-07-21 -38.59
2026-07-20 -38.59
2026-07-17 -38.59
2026-07-16 -38.15